Matthew W. McClure

Insider Reports History

Entity
Individual
Location
C/O Aligos Therapeutics, Inc., 1 Corporate Drive, 2 Nd Floor, South San Francisco, CA
Signature
/s/ Lesley Ann Calhoun, as attorney-in fact for Matthew W. McClure
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew W. McClure:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aligos Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 72K Mar 1, 2024 Direct

Insider Reports Filed by Matthew W. McClure

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALGS Aligos Therapeutics, Inc. Mar 1, 2024 1 $0 4 Mar 4, 2024 Chief Medical Officer
ALGS Aligos Therapeutics, Inc. Feb 27, 2024 6 $0 4 Feb 28, 2024 Chief Medical Officer
ALGS Aligos Therapeutics, Inc. Sep 8, 2023 1 $0 4 Sep 12, 2023 Chief Medical Officer
ALGS Aligos Therapeutics, Inc. Mar 15, 2023 1 $0 4 Mar 17, 2023 Chief Medical Officer
ALGS Aligos Therapeutics, Inc. Jul 7, 2022 1 $0 4 Jul 11, 2022 Chief Medical Officer
ALGS Aligos Therapeutics, Inc. Apr 27, 2022 0 $0 3 May 6, 2022 Chief Medical Officer